Why impartiality matters more for accredited laboratories than the wording suggests

Accreditation exists to give a result external credibility: a client, a regulator or a court relies on an accredited result precisely because the laboratory is presumed to have no stake in what that result says. That presumption is what clause 4 protects, and it is why the requirement extends beyond avoiding actual bias to managing the appearance of bias. A few situations illustrate why this is particularly significant for accredited laboratories:

• Laboratories embedded within a manufacturer or supplier. An in-house or captive laboratory testing its own organisation's products faces an inherent structural risk that has to be actively managed and documented, not simply acknowledged.
• Commercial dependence on a small number of clients. Where a large share of revenue comes from one client, the risk of pressure — subtle or otherwise — to deliver a favourable result increases, and the laboratory needs a defined response to that risk.
• Consulting or advisory work alongside testing. A laboratory that both advises a client on how to meet a specification and then tests against that same specification creates a self-interest risk that needs to be identified and addressed.
• Personnel movement between a laboratory and the entities it serves. Staff who move from a client organisation into the laboratory, or vice versa, can introduce relationships that need to be recorded and evaluated.

In each case, the standard does not necessarily prohibit the activity — it requires the laboratory to identify the risk, evaluate its significance, and show what it has done to eliminate or minimise it. A risk that is acknowledged and controlled is treated very differently from one that goes unrecognised.

4.2 Confidentiality: protecting client information through the laboratory's activities

Clause 4.2 requires the laboratory to be responsible, through legally enforceable commitments, for the management of all information obtained or created during the performance of laboratory activities. This covers results, but it also covers ownership information, sample details, test methods used, and any other information a client would reasonably expect to be kept confidential. Key elements of the requirement include:

• Informing the client in advance of any information the laboratory intends to place in the public domain, except where the client has made that information publicly available itself, or where the laboratory and client have agreed otherwise (for example, in response to a complaint).
• Handling information received from sources other than the client (such as complainants, regulators or other stakeholders) confidentially, and protecting the confidentiality of the source's identity.
• Personnel obligations — including committees, contractors, external bodies and individuals acting on the laboratory's behalf — must keep confidential all information obtained or created during laboratory activities, except as required by law.
• Legal disclosure — where a laboratory is required by law, or authorised by contractual arrangements, to release confidential information, the client or individual concerned must be notified of the information provided, unless prohibited by law.

Practical impact: what clause 4 asks a laboratory to actually build

Meeting clause 4 in practice generally means putting the following in place, rather than treating impartiality and confidentiality as abstract principles stated once in a policy document:

• A documented impartiality risk identification and review process that is revisited when circumstances change, not only at a fixed annual interval.
• Top management commitment to impartiality, expressed in policy and reinforced through how staff are managed, evaluated and remunerated — reward structures tied narrowly to client satisfaction or pass rates can themselves become a source of risk.
• Legally enforceable confidentiality commitments covering all personnel, including external and contracted staff, and committee members who may see client information.
• Clear rules on what happens when disclosure is required by law, including who is responsible for notifying the client and how that notification is recorded.
• Segregation or documented safeguards where the laboratory also provides consulting, calibration equipment sales, or other services that could create a conflict with its testing or calibration role.

Common audit findings on clause 4

• Impartiality policy exists but the risk assessment behind it does not. A signed statement of commitment to impartiality with no underlying, laboratory-specific analysis of where risk actually arises.
• Risk register not kept current. No evidence that the impartiality risk assessment has been revisited following a relevant change, such as a new client relationship, a change in ownership, or a new service line.
• Confidentiality agreements missing for contracted or external personnel. Employment contracts cover permanent staff, but committee members, subcontractors or external assessors involved in laboratory activities have no equivalent, legally enforceable commitment on file.
• No documented process for public-domain disclosures. The laboratory cannot show how or when it notifies a client in advance of information it intends to make public.
• Unmanaged structural conflicts. A laboratory embedded within, or commercially dependent on, an organisation whose products it tests, with no documented mitigation beyond a general statement of independence.
• Remuneration or incentive structures that create pressure. Staff bonuses or targets linked to client volume or satisfaction scores, without any documented safeguard addressing the resulting pressure on results.

Frequently asked questions about ISO 17025 clause 4

What does "impartiality" mean under ISO/IEC 17025:2017?

Impartiality means laboratory activities are carried out, and results are produced, without being influenced by commercial, financial, organisational or personal interests. Clause 4.1 requires the laboratory to identify risks to that impartiality on an ongoing basis and to be able to demonstrate how it eliminates or minimises them, rather than simply declaring itself impartial.

Can a laboratory that is part of a manufacturing company still be accredited?

This depends on how the risk is identified and managed, and it is a matter to work through with your accreditation body rather than assume in either direction. The standard does not automatically disqualify an in-house or affiliated laboratory, but it requires that structural risk to be recognised and documented, with evidence of the safeguards in place.

How often should the impartiality risk assessment be reviewed?

The clause requires this to be ongoing, so a fixed annual review alone is generally not considered sufficient on its own. In practice, the assessment should also be revisited whenever something changes that could introduce a new risk — a new client, a change of ownership, a new service line, or a relevant personnel change.

Does confidentiality under clause 4.2 apply to subcontractors and committee members?

Yes. The requirement extends to all personnel acting on the laboratory's behalf, including contracted personnel and members of committees, and the laboratory must be able to show a legally enforceable commitment to confidentiality is in place for each.

What happens if a laboratory is legally required to disclose confidential information?

Where disclosure is required by law or authorised by contractual arrangements, the client or individual concerned must be informed of the information provided, unless the law itself prohibits that notification. The laboratory should have a documented process describing how this notification is handled.

Is a signed impartiality declaration from staff enough to satisfy clause 4?

On its own, generally not. Assessors look for evidence of an underlying risk identification and management process behind the declaration — records showing that specific risks were considered, evaluated and addressed — rather than a single signed statement with no supporting analysis.

Can commercial pressure from a client be treated as an impartiality risk even without a formal complaint?

Yes. Clause 4.1 asks the laboratory to identify risks proactively, not only in response to an incident. Commercial dependence on a client, or informal pressure to reach a particular outcome, should be recognised and addressed as a risk in its own right, whether or not it has ever led to a formal complaint or nonconformity.

Expert ISO 17025 · Updated 2026-09-25